127 results
Page 5 of 7
8-K
EX-99.2
izy1xls66u1wdgpseu
18 Mar 21
Aeglea BioTherapeutics Reports Fourth Quarter and Full Year 2020 Financial Results and Corporate Highlights
8:31am
8-K
EX-99.1
esqo4m6e71eimyd
5 Jan 21
Regulation FD Disclosure
8:30am
8-K
EX-1.1
008mz2rn1ai 1g
28 Apr 20
Entry into a Material Definitive Agreement
4:28pm
8-K
EX-99.1
35bpd
27 Apr 20
Regulation FD Disclosure
4:18pm
424B5
fl6ry5lgs
16 Apr 20
Prospectus supplement for primary offering
8:44am
8-K
EX-99.2
ub787vxds
13 Jan 20
Company Expects to Initiate a Phase 1/2 Trial in the Second Quarter of 2020
7:01am
S-8
c5nta knai
7 Mar 19
Registration of securities for employees
5:16pm